Nonoperating Income (Expense) of CervoMed Inc. from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
CervoMed Inc. quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • CervoMed Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $317,560, a 51% decline year-over-year.
  • CervoMed Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $1,619,188, a 6.6% increase year-over-year.
  • CervoMed Inc. annual Nonoperating Income (Expense) for 2024 was $1,936,436, a 66% decline from 2023.
  • CervoMed Inc. annual Nonoperating Income (Expense) for 2023 was $5,641,022.
  • CervoMed Inc. annual Nonoperating Income (Expense) for 2022 was $2,327,513.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

CervoMed Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,619,188 $317,560 -$325,172 -51% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $1,944,360 $357,871 -$320,323 -47% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $2,264,683 $408,850 +$328,247 +407% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $1,936,436 $534,907 +$416,855 +353% 01 Oct 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q3 2024 $1,519,581 $642,732 -$4,182,759 -87% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $5,702,340 $678,194 +$872,698 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 $4,829,642 $80,603 -$811,380 -91% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $5,641,022 $118,052 01 Oct 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q3 2023 $4,825,491 +$4,804,060 +22416% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $194,504 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $891,983 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q3 2022 $21,431 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q4 2015 $6,357 $1,039 -$375,468 -100% 01 Oct 2015 31 Dec 2015 10-K 25 Mar 2016 2015 FY
Q3 2015 $381,825 $1,165 +$84,684 01 Jul 2015 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 $297,141 $1,633 +$2,841,856 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2015 2015 Q2
Q1 2015 $2,544,715 $2,520 +$11,175 01 Jan 2015 31 Mar 2015 10-Q 11 May 2015 2015 FY
Q4 2014 $2,555,890 $376,507 +$1,414,603 01 Oct 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
Q3 2014 $3,970,493 $83,519 -$119,598 -331% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2015 2015 Q3
Q2 2014 $3,850,895 $2,840,223 -$13,413,960 -127% 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015 2015 Q2
Q1 2014 $9,563,065 $8,655 -$265,912 -103% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 FY
Q4 2013 $9,828,977 $1,038,096 +$3,806,424 +79% 01 Oct 2013 31 Dec 2013 10-K 03 Apr 2015 2014 FY
Q3 2013 $6,022,553 $36,079 +$74,366 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014 2014 Q3
Q2 2013 $5,948,187 $10,573,737 +$12,677,984 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2014 Q2
Q1 2013 $6,729,797 $257,257 -$1,787,743 -87% 01 Jan 2013 31 Mar 2013 10-Q 20 May 2014 2014 Q1
Q4 2012 $4,942,054 $4,844,520 01 Oct 2012 31 Dec 2012 10-K/A 23 Apr 2014 2013 FY
Q3 2012 $38,287 +$157,418 +80% 01 Jul 2012 30 Sep 2012 10-Q 19 Nov 2012 2012 Q3
Q2 2012 $2,104,247 -$2,015,411 -2269% 01 Apr 2012 30 Jun 2012 10-Q 19 Nov 2013 2013 Q3
Q1 2012 $2,045,000 01 Jan 2012 31 Mar 2012 10-Q/A 20 May 2013 2013 Q1
Q3 2011 $195,705 -$6,269 -3.3% 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012 2012 Q3
Q2 2011 $88,836 -$70,961 -397% 01 Apr 2011 30 Jun 2011 10-Q/A 07 Sep 2012 2012 Q2
Q3 2010 $189,436 01 Jul 2010 30 Sep 2010 10-Q 21 Nov 2011 2011 Q3
Q2 2010 $17,875 01 Apr 2010 30 Jun 2010 10-Q 16 Aug 2011 2011 Q2

CervoMed Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,936,436 -$3,704,586 -66% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2025 2024 FY
2023 $5,641,022 +$7,968,535 01 Jan 2023 31 Dec 2023 10-K 17 Mar 2025 2024 FY
2022 $2,327,513 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
2015 $6,357 +$2,562,247 01 Jan 2015 31 Dec 2015 10-K 25 Mar 2016 2015 FY
2014 $2,555,890 -$12,384,867 -126% 01 Jan 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
2013 $9,828,977 +$14,771,031 01 Jan 2013 31 Dec 2013 10-K 03 Apr 2015 2014 FY
2012 $4,942,054 +$1,264,436 +20% 01 Jan 2012 31 Dec 2012 10-K/A 23 Apr 2014 2013 FY
2011 $6,206,490 -$5,433,841 -703% 01 Jan 2011 31 Dec 2011 10-K/A 24 Apr 2013 2012 FY
2010 $772,649 01 Jan 2010 31 Dec 2010 10-K 21 May 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.